(Q33203656)

23 July 2017

Prolonging the action of protein and peptide drugs by a novel approach of reversible polyethylene glycol modification (English)

1 reference

23 July 2017

Haim Tsubery

1

1 reference

23 July 2017

Marina Mironchik

series ordinal

2

1 reference

23 July 2017

Mati Fridkin

series ordinal

3

1 reference

23 July 2017

Yoram Shechter

series ordinal

4

1 reference

23 July 2017

language of work or name

English

0 references

publication date

8 June 2004

1 reference

Journal of Biological Chemistry

23 July 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

23 July 2017

279

1 reference

23 July 2017

37

1 reference

23 July 2017

38118-38124

1 reference

Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs

23 July 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405155200

Peptide and protein PEGylation: a review of problems and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405155200

Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405155200

Use of peginterferon alfa-2a (40 KD) (Pegasys) for the treatment of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405155200

Drug delivery systems employing 1,6-elimination: releasable poly(ethylene glycol) conjugates of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405155200

The preparation and properties of novel reversible polymer-protein conjugates. 2-omega-Methoxypolyethylene (5000) glycoxymethylene-3-methylmaleyl conjugates of plasminogen activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405155200

New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405155200

Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-alpha 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405155200

Characteristics of solubilized human-somatotropin-binding protein from the liver of pregnant rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405155200

2-Sulfo-9-fluorenylmethoxycarbonyl3–exendin-4—a long-acting glucose-lowering prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405155200

Chemistry for peptide and protein PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405155200

AN IMPROVED SYNTHESIS OF N-[(9-HYDROXYMETHYL)-2-FLUORENYL]SUCCINAMIC ACID (HMFS), A VERSATILE HANDLE FOR THE SOLID-PHASE SYNTHESIS OF BIOMOLECULES

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405155200

Exendin-4 and exendin-(9–39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7–36)NH2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405155200

21 January 2018

Identifiers

DOI

10.1074/JBC.M405155200

1 reference

23 July 2017

1 reference